Showing results (311-320 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|September 17, 2011
Use of mathematical models to understand anticancer drug delivery and its effect on solid tumorsCong Li, J Krishnan, Justin Stebbing, et al.Pharmacogenomics|September 10, 2011
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaArnaud G L'Huillier, Kuntheavy Ing Lorenzini, Pierre-Alex Crisinel, et al.Pharmacogenomics|July 21, 2011
The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipientsHylke de Jonge, Christoph Metalidis, Maarten Naesens, et al.Pharmacogenomics|October 4, 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifenAnn M Moyer, Vera J Suman, Richard M Weinshilboum, et al.Pharmacogenomics|October 20, 2011
Pharmacogenetics in randomized controlled trials: considerations for trial designFrederieke H van der Baan, Olaf H Klungel, Antoine C G Egberts, et al.Pharmacogenomics|November 3, 2011
Genetic and genomic predictors of anti-TNF responseRita Prajapati, Darren Plant, Anne BartonPharmacogenomics|November 3, 2011
Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-callsAndrea Gaedigk, Juanjo Hernandez, Virginia García-Solaesa, et al.Pharmacogenomics|March 3, 2012
GeneNews Limited: bringing the blood transcriptome to personalized medicineDavid J Novak, Gailina J Liew, Choong-Chin LiewPharmacogenomics|March 3, 2012
Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicineKonstantinos Mitropoulos, Federico Innocenti, Ron H van Schaik, et al.Pharmacogenomics|March 3, 2012
Pharmacogenetics of antidepressant drugs: current clinical practice and future directionsSneha Narasimhan, Falk W LohoffPageof 276